ArticleClinical genitourinary cancer2024

Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN).

Damla Gunenc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.